117 related articles for article (PubMed ID: 10680102)
1. Course of molecular hemostatic markers during and after different surgical procedures.
Siemens HJ; Brueckner S; Hagelberg S; Wagner T; Schmucker P
J Clin Anesth; 1999 Dec; 11(8):622-9. PubMed ID: 10680102
[TBL] [Abstract][Full Text] [Related]
2. Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty.
Brueckner S; Reinke U; Roth-Isigkeit A; Eleftheriadis S; Schmucker P; Siemens HJ
J Clin Anesth; 2003 Sep; 15(6):433-40. PubMed ID: 14652120
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of hemostatic markers under different techniques for anesthesia-analgesia in total hip or knee replacement].
de la Fuente Tornero E; Garutti Martínez I; Gutiérrez Tonal B; Rodríguez Huertas A; Chana Rodríguez F; Villanueva Martínez M; Pascual Izquierdo C
Rev Esp Anestesiol Reanim; 2010; 57(6):333-40. PubMed ID: 20645484
[TBL] [Abstract][Full Text] [Related]
4. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
5. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic markers in surgery: a different fibrinolytic activity may be of pathophysiological significance in orthopedic versus abdominal surgery.
López Y; Páramo JA; Valentí JR; Pardo F; Montes R; Rocha E
Int J Clin Lab Res; 1997; 27(4):233-7. PubMed ID: 9506266
[TBL] [Abstract][Full Text] [Related]
7. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
Topper MJ; Prasse KW
Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
[TBL] [Abstract][Full Text] [Related]
8. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
9. Alterations of hemostasis after laparoscopic and open surgery.
Diamantis T; Tsiminikakis N; Skordylaki A; Samiotaki F; Vernadakis S; Bongiorni C; Tsagarakis N; Marikakis F; Bramis I; Bastounis E
Hematology; 2007 Dec; 12(6):561-70. PubMed ID: 17852431
[TBL] [Abstract][Full Text] [Related]
10. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
[TBL] [Abstract][Full Text] [Related]
11. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
13. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery.
Modrau II; Iversen LL; Thorlacius-Ussing OO
Thromb Res; 2001 Dec; 104(5):309-15. PubMed ID: 11738072
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
[TBL] [Abstract][Full Text] [Related]
17. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
Koyama T; Kakishita E; Nakai Y; Okamoto E
Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
[TBL] [Abstract][Full Text] [Related]
18. The molecular markers of hemostatic activation on coronary artery disease.
Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
[TBL] [Abstract][Full Text] [Related]
19. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
